Rituximab Tied to Increased Infection Risk in RRMS
The B-cell–depleting drug rituximab was associated with a twofold increased risk for infection in patients with relapsing-remitting multiple sclerosis (RRMS), ...
Read moreThe B-cell–depleting drug rituximab was associated with a twofold increased risk for infection in patients with relapsing-remitting multiple sclerosis (RRMS), ...
Read moreTOPLINE:Patients with pemphigus who received rituximab as first-line therapy experienced sustained remission without corticosteroids or additional rituximab infusions, an analysis ...
Read more© 2023 earth-news.info
..................................%%%...*...........................................$$$$$$$$$$$$$$$$$$$$--------------------.....